BROOKFIELD Corp ON raised its holdings in shares of American Tower Corporation (NYSE:AMT - Free Report) by 50.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 478,559 shares of the real estate investment trust's stock after purchasing an additional 159,449 shares during the period. American Tower comprises about 0.6% of BROOKFIELD Corp ON's portfolio, making the stock its 23rd largest holding. BROOKFIELD Corp ON owned approximately 0.10% of American Tower worth $104,134,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. North Capital Inc. bought a new stake in American Tower during the first quarter valued at $25,000. Hopwood Financial Services Inc. lifted its stake in American Tower by 100.0% in the first quarter. Hopwood Financial Services Inc. now owns 120 shares of the real estate investment trust's stock valued at $26,000 after buying an additional 60 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. bought a new stake in American Tower in the first quarter valued at $31,000. Lowe Wealth Advisors LLC lifted its stake in American Tower by 218.0% in the first quarter. Lowe Wealth Advisors LLC now owns 159 shares of the real estate investment trust's stock valued at $35,000 after buying an additional 109 shares during the last quarter. Finally, City Holding Co. bought a new stake in American Tower in the first quarter valued at $39,000. Institutional investors own 92.69% of the company's stock.
Insider Activity at American Tower
In other news, CEO Juan Font sold 720 shares of the business's stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $208.33, for a total value of $149,997.60. Following the sale, the chief executive officer owned 23,425 shares of the company's stock, valued at approximately $4,880,130.25. The trade was a 2.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.17% of the company's stock.
American Tower Trading Up 1.4%
NYSE:AMT opened at $196.44 on Friday. American Tower Corporation has a 1 year low of $172.51 and a 1 year high of $241.97. The stock has a market cap of $91.98 billion, a price-to-earnings ratio of 71.43, a PEG ratio of 1.20 and a beta of 0.86. The business has a fifty day moving average of $211.36 and a 200-day moving average of $213.42. The company has a debt-to-equity ratio of 3.36, a quick ratio of 0.95 and a current ratio of 0.95.
American Tower (NYSE:AMT - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The real estate investment trust reported $2.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.59 by $0.01. American Tower had a return on equity of 24.85% and a net margin of 12.60%.The company had revenue of $2.63 billion during the quarter, compared to analysts' expectations of $2.58 billion. During the same quarter in the prior year, the business posted $2.79 earnings per share. The company's revenue for the quarter was down 9.4% compared to the same quarter last year. American Tower has set its FY 2025 guidance at 10.460-10.650 EPS. Equities analysts predict that American Tower Corporation will post 10.14 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of research firms have issued reports on AMT. The Goldman Sachs Group reiterated a "buy" rating on shares of American Tower in a research note on Tuesday, July 29th. Raymond James Financial set a $250.00 target price on American Tower and gave the company a "strong-buy" rating in a research note on Wednesday, July 30th. HSBC cut American Tower from a "buy" rating to a "hold" rating and set a $235.00 target price on the stock. in a research note on Wednesday, July 30th. Barclays raised their target price on American Tower from $246.00 to $250.00 and gave the company an "overweight" rating in a research note on Monday, August 18th. Finally, UBS Group raised their target price on American Tower from $250.00 to $260.00 and gave the company a "buy" rating in a research note on Tuesday, July 8th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $244.73.
Get Our Latest Report on AMT
About American Tower
(
Free Report)
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider American Tower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Tower wasn't on the list.
While American Tower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.